SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Mechanism: evolutionary-scale-modeling-esm

mechanism 2,010 words KG: MSA

Contents

evolutionary-scale-modeling-esm

⚙ Mechanism Info

Name	MSA
Key Genes/Proteins	alpha_synuclein
Related Diseases	synucleinopathies

Knowledge Graph

Related Hypotheses (30)

TREM2-mediated microglial tau clearance enhancement
Score: 0.49 Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53 Cryptic Exon Silencing Restoration
Score: 0.46 APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54 Cross-Seeding Prevention Strategy
Score: 0.45

Smartphone-Detected Motor Variability Correction
Score: 0.56 Glycine-Rich Domain Competitive Inhibition
Score: 0.43 Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41 Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51 Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.45 Competitive APOE4 Domain Stabilization Peptides
Score: 0.56 Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.44 Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.41 Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46 TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen
Score: 0.64 TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
Score: 0.61 Multiplexed Base Editing for Simultaneous Neuroprotective Ge
Score: 0.53 Acid-Degradable LNP-Mediated Prenatal CRISPR Intervention fo
Score: 0.47 TREM2-Dependent Microglial Senescence Transition
Score: 0.69 Prime Editing Precision Correction of APOE4 to APOE3 in Micr
Score: 0.62 Glymphatic-Mediated Tau Clearance Dysfunction
Score: 0.55 Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52 Dual-Circuit Tau Vulnerability Cascade
Score: 0.50 Dopaminergic Ventral Tegmental-Hippocampal Circuit Protectio
Score: 0.49 APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49 APOE-TREM2 Interaction Modulation
Score: 0.48 APOE Isoform Expression Across Glial Subtypes
Score: 0.48 Conditional CRISPR Kill Switches for Aberrant Protein Cleara
Score: 0.45 APOE Isoform Conversion Therapy
Score: 0.44

Related Analyses (30)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived

Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived 4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed Mitochondrial transfer between neurons and glia
neurodegeneration · archived Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived

Related Experiments (11)

Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel
validation · proposed · Score: 0.40 LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne
validation · proposed · Score: 0.40 Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.40 TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.40 TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.40

Tau depletion effects on neuronal development in primary cul
exploratory · proposed · Score: 0.90 Microtubule domain analysis in adult axons
exploratory · proposed · Score: 0.80 AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40 AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40 Pre-Symptomatic Tau Detection in MAPT Mutation Carriers
clinical · proposed · Score: 0.40 Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.40

Knowledge Graph (11 edges)

MSA contributes_to synucleinopathies

MSA co_discussed PARKINSON

MSA co_discussed PARKINSON'S

MSA associated_with NEURODEGENERATION

MSA associated_with SCHIZOPHRENIA

alpha_synuclein causes MSA

HAND associated_with MSA

ALS associated_with MSA

AUTISM associated_with MSA

DEPRESSION associated_with MSA

SciDEX — scidex.ai — Dashboard | Atlas